HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark J Field Selected Research

CI 1021

11/2002Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark J Field Research Topics

Disease

5Neuralgia (Stump Neuralgia)
08/2010 - 11/2002
4Pain (Aches)
05/2012 - 11/2004
3Hyperalgesia
08/2010 - 11/2002
1Chronic Pain
05/2012
1Osteoarthritis
11/2004
1Nociceptive Pain
11/2004

Drug/Important Bio-Agent (IBA)

3Pregabalin (Lyrica)FDA Link
08/2010 - 11/2006
3Gabapentin (Neurontin)FDA LinkGeneric
01/2010 - 11/2002
2Calcium Channels (Calcium Channel)IBA
05/2007 - 11/2006
2Analgesics (Analgesic Drugs)IBA
11/2006 - 11/2004
1Sildenafil Citrate (Viagra)FDA Link
08/2010
1compound 21IBA
01/2010
1LigandsIBA
05/2007
1Proteins (Proteins, Gene)FDA Link
05/2007
1Butyric Acid (Butanoic Acid)IBA
05/2007
1Narcotics (Narcotic Analgesics)IBA
11/2006
1Morphine (MS Contin)FDA LinkGeneric
11/2004
1Tramadol (K315)FDA LinkGeneric
11/2004
1Pharmaceutical PreparationsIBA
11/2004
1Iodoacetic AcidIBA
11/2004
1CI 1021IBA
11/2002
1EstersIBA
11/2002
1Streptozocin (Streptozotocin)FDA Link
11/2002
1Neurokinin-1 Receptor AntagonistsIBA
11/2002
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
11/2002

Therapy/Procedure

1Therapeutics
05/2012
1Intra-Articular Injections
11/2004